High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$2.7M
$2,713,562
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
IONS
S
IONIS PHARMACEUTICALS INC
Baroldi Joseph
• Officer • EVP, Chief Business Officer
10b5-1 Sell
2026-03-04
$35,120x2
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Business Officer
10b5-1 Sell
|
2026-03-04 | $35,120x2 | S | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Baroldi Joseph
• Officer • EVP, Chief Business Officer
10b5-1 Sell
2026-03-03
$495,867x3
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Business Officer
10b5-1 Sell
|
2026-03-03 | $495,867x3 | S | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Baroldi Joseph
• Officer • EVP, Chief Business Officer
Discretionary SellΔOwn -10.4%
2026-01-30
$439,364
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Business Officer
Discretionary SellΔOwn -10.4%
|
2026-01-30 | $439,364 | S | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Baroldi Joseph
• Officer • EVP, Chief Business Officer
Sell to CoverΔOwn -14.6%
2026-01-16
$610,276x2
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Business Officer
Sell to CoverΔOwn -14.6%
|
2026-01-16 | $610,276x2 | S | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Baroldi Joseph
• Officer • EVP, Chief Business Officer
10b5-1 Sell
2025-10-06
$112,725
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Business Officer
10b5-1 Sell
|
2025-10-06 | $112,725 | S | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Baroldi Joseph
• Officer • EVP, Chief Business Officer
10b5-1 SellΔOwn -32.0%
2025-10-02
$1,020,210Large
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Business Officer
10b5-1 SellΔOwn -32.0%
|
2025-10-02 | $1,020,210Large | S | Form 4 |